DDIT3 and cancer: The combination of bortezomib with eeyarestatin massively increased the accumulation of polyubiquitinated proteins in cancer cells, induced macroautophagy, and activated the pro-apoptotic ATF4/CHOP/NOXA-mediated pathway of the ER-stress response (131, 132).